Reflection Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$742K Buy
2,835
+53
+2% +$13.6K 0.31% 74
2026
Q2
$700K Buy
2,782
+263
+10% +$56.6K 0.33% 67
2026
Q1
$548K Buy
2,519
+502
+25% +$111K 0.34% 70
2025
Q4
$461K Buy
+2,017
New +$459K 0.33% 65

Other funds holding ABBV

Reflection Asset Management's ABBV Position: Q3 2026 in Review

Reflection Asset Management increased its AbbVie (ABBV) stake by 1.9% in Q3 2026, buying an estimated $13.6K and bringing the position to 2,835 shares worth $742K. The position accounts for 0.31% of the portfolio, ranked #74.

Reflection Asset Management first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Reflection Asset Management held 2,835 shares of AbbVie worth $742K as of Q3 2026.
  • Reflection Asset Management bought 53 AbbVie shares in Q3 2026, an estimated $13.6K.
  • AbbVie made up 0.31% of Reflection Asset Management's portfolio in Q3 2026, its #74 holding.
  • Reflection Asset Management first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Reflection Asset Management's 13F filing for Q3 2026, filed 28 Oct 2026.